Several previous studies suggest that the density and location of infiltrating CD3+, CD8+, and CD45RO+ cells are significant prognostic biomarkers, leading to a new scoring system designated “Immunoscore”, a powerful tool for the classification of malignant tumors [30, 31]. The gene discussed is CD8A; the disease is cancer.